Get started
RocketTickers

Tezepelumab Granted Breakthrough Therapy Designation By US FDA

Long
Amgen Inc. (NASDAQ:AMGN)  
RocketTickers  
NASDAQ:AMGN   Amgen Inc.
Beyond Technical Analysis
1
0
beyondta
AMGN : Amgen
2018-09-07 02:00:00
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.